Home
Conditions
Eye Neoplasms

Clinical trial condition

Eye Neoplasms

Explore clinical trials studying Eye Neoplasms. Study availability and eligibility vary by location and protocol.

396 public trials 62 recruiting studies

Refine in advanced search Browse all conditions

Eye Neoplasms trial results

Not Yet Recruiting

Post-Market Clinical Follow-Up Study on the Rotational Stability of an Intraocular Lens After Cataract Surgery

NCT07099079

Conditions: Cataract, Eye Diseases, Eye Neoplasms, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

ZR-MTX for PIOL Phase II Trial

NCT06973811

Conditions: Eye Neoplasms, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases

NCT05903937

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)

NCT05282901

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +19 more
Locations: Institut Curie Paris, France

View Trial Details

Completed

Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery

NCT04235803

Conditions: Blepharoptosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +20 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver

NCT03472586

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

NCT01989572

Conditions: Eye Diseases, Eye Neoplasms, Iris Melanoma, +34 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Mobile Infirmary Medical Center Mobile, Alabama, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 148 locations

View Trial Details

Completed

The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes

NCT06279143

Conditions: BCC, BCC - Basal Cell Carcinoma, Carcinoma, +22 more
Locations: Department of Ophthalmology, University Hospital of Southern Denmark, Vejle Hospital Vejle, Region of Southern Danmark, Denmark

View Trial Details

Completed

Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma

NCT05187884

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations: Kinghorn Cancer Centre, St. Vincent's Hospital Sydney, New South Wales, Australia

Alfred Hospital Melbourne, Victoria, Australia

View Trial Details

Completed

Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma

NCT05628883

Conditions: Acral Melanoma, Conjunctival Melanoma, Cutaneous Melanoma, +23 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Eye Neoplasms

Eye Neoplasms trial results

Related conditions